Fundraising Fox

Chaperone Therapeutics

Chapel Hill, US · Delaware corporation

Founders & leadership

KM
Kalpana MerchantExecutive
DT
Dennis ThieleNamed on SEC filing
MS
Maria Sippola-ThieleNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$456.6K disclosed across 1 round · 2016

$456.6KraisedJan 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalpana MerchantExecutive Officer
  • Dennis ThieleExecutive Officer, Director
  • Maria Sippola-ThieleExecutive Officer, Director, Promoter
Offering amount
$900K
Amount sold
$456.6K
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Chaperone Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$3M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2016$270K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has Chaperone Therapeutics raised?
Chaperone Therapeutics has disclosed $456.6K raised across 1 round.
Where is Chaperone Therapeutics headquartered?
Chaperone Therapeutics is headquartered in Chapel Hill, US.